FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting

Data ReadoutpositiveFSdC Spheroids (Fibroblast Spheroid-Derived Chondrocyte Spheroids)Positive

AI Analysis

Summary

FibroBiologics presented preclinical data at the North American Spine Society 2026 Annual Meeting showing FSdC spheroids preserved disc height better than any other fibroblast-based approach tested in a 12-week rabbit model of degenerative disc disease.

Outcome Details

FSdC spheroids preserved disc height better than any other fibroblast-based approach tested in a 12-week rabbit model of degenerative disc disease.

Importance:4/10

Sentiment:

0.50

preclinicaldegenerative disc diseasecell therapyfibroblastspheroidsNASS 2026conference presentationorthopedics

Related Companies

$FBLG

Read the original article

Published by PR Newswire Biotech on October 19, 2026 12:30 PM

Read Original